UniProt ID | TET3_MOUSE | |
---|---|---|
UniProt AC | Q8BG87 | |
Protein Name | Methylcytosine dioxygenase TET3 | |
Gene Name | Tet3 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1668 | |
Subcellular Localization | Nucleus . Chromosome . Cytoplasm . At the zygotic stage, localizes in the male pronucleus, while it localizes to the cytoplasm at other preimplantation stages (PubMed:21892189). Binds to the promoter of target genes, close to the transcription start | |
Protein Description | Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in epigenetic chromatin reprogramming in the zygote following fertilization. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Selectively binds to the promoter region of target genes and contributes to regulate the expression of numerous developmental genes. In zygotes, DNA demethylation occurs selectively in the paternal pronucleus before the first cell division, while the adjacent maternal pronucleus and certain paternally-imprinted loci are protected from this process. Participates in DNA demethylation in the paternal pronucleus by mediating conversion of 5mC into 5hmC, 5fC and 5caC. Does not mediate DNA demethylation of maternal pronucleus because of the presence of DPPA3/PGC7 on maternal chromatin that prevents TET3-binding to chromatin. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.; Isoform 3: Has higher affinity for DNA and lower catalytic activity than isoform 1, probably due to the N-terminal CXXC-type zinc-finger domain that mediates high-affinity binding to DNA and that is not present in isoform 1.. | |
Protein Sequence | MDSGPVYHGDSRQLSTSGAPVNGAREPAGPGLLGAAGPWRVDQKPDWEAASGPTHAARLEDAHDLVAFSAVAEAVSSYGALSTRLYETFNREMSREAGSNGRGPRPESCSEGSEDLDTLQTALALARHGMKPPNCTCDGPECPDFLEWLEGKIKSMAMEGGQGRPRLPGALPPSEAGLPAPSTRPPLLSSEVPQVPPLEGLPLSQSALSIAKEKNISLQTAIAIEALTQLSSALPQPSHSTSQASCPLPEALSPSAPFRSPQSYLRAPSWPVVPPEEHPSFAPDSPAFPPATPRPEFSEAWGTDTPPATPRNSWPVPRPSPDPMAELEQLLGSASDYIQSVFKRPEALPTKPKVKVEAPSSSPAPVPSPISQREAPLLSSEPDTHQKAQTALQQHLHHKRNLFLEQAQDASFPTSTEPQAPGWWAPPGSPAPRPPDKPPKEKKKKPPTPAGGPVGAEKTTPGIKTSVRKPIQIKKSRSRDMQPLFLPVRQIVLEGLKPQASEGQAPLPAQLSVPPPASQGAASQSCATPLTPEPSLALFAPSPSGDSLLPPTQEMRSPSPMVALQSGSTGGPLPPADDKLEELIRQFEAEFGDSFGLPGPPSVPIQEPENQSTCLPAPESPFATRSPKKIKIESSGAVTVLSTTCFHSEEGGQEATPTKAENPLTPTLSGFLESPLKYLDTPTKSLLDTPAKKAQSEFPTCDCVEQIVEKDEGPYYTHLGSGPTVASIRELMEDRYGEKGKAIRIEKVIYTGKEGKSSRGCPIAKWVIRRHTLEEKLLCLVRHRAGHHCQNAVIVILILAWEGIPRSLGDTLYQELTDTLRKYGNPTSRRCGLNDDRTCACQGKDPNTCGASFSFGCSWSMYFNGCKYARSKTPRKFRLTGDNPKEEEVLRNSFQDLATEVAPLYKRLAPQAYQNQVTNEDVAIDCRLGLKEGRPFSGVTACMDFCAHAHKDQHNLYNGCTVVCTLTKEDNRCVGQIPEDEQLHVLPLYKMASTDEFGSEENQNAKVSSGAIQVLTAFPREVRRLPEPAKSCRQRQLEARKAAAEKKKLQKEKLSTPEKIKQEALELAGVTTDPGLSLKGGLSQQSLKPSLKVEPQNHFSSFKYSGNAVVESYSVLGSCRPSDPYSMSSVYSYHSRYAQPGLASVNGFHSKYTLPSFGYYGFPSSNPVFPSQFLGPSAWGHGGSGGSFEKKPDLHALHNSLNPAYGGAEFAELPGQAVATDNHHPIPHHQQPAYPGPKEYLLPKVPQLHPASRDPSPFAQSSSCYNRSIKQEPIDPLTQAESIPRDSAKMSRTPLPEASQNGGPSHLWGQYSGGPSMSPKRTNSVGGNWGVFPPGESPTIVPDKLNSFGASCLTPSHFPESQWGLFTGEGQQSAPHAGARLRGKPWSPCKFGNGTSALTGPSLTEKPWGMGTGDFNPALKGGPGFQDKLWNPVKVEEGRIPTPGANPLDKAWQAFGMPLSSNEKLFGALKSEEKLWDPFSLEEGTAEEPPSKGVVKEEKSGPTVEEDEEELWSDSEHNFLDENIGGVAVAPAHCSILIECARRELHATTPLKKPNRCHPTRISLVFYQHKNLNQPNHGLALWEAKMKQLAERARQRQEEAARLGLGQQEAKLYGKKRKWGGAMVAEPQHKEKKGAIPTRQALAMPTDSAVTVSSYAYTKVTGPYSRWI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
51 | O-linked_Glycosylation | KPDWEAASGPTHAAR CCCHHHCCCCCCHHH | 52.97 | 105050833 | |
121 (in isoform 4) | Phosphorylation | - | 27.10 | 30635358 | |
123 (in isoform 4) | Phosphorylation | - | 4.57 | 30635358 | |
126 (in isoform 4) | Phosphorylation | - | 8.87 | 30635358 | |
320 | Phosphorylation | SWPVPRPSPDPMAEL CCCCCCCCCCHHHHH | 43.12 | - | |
360 | O-linked_Glycosylation | KVKVEAPSSSPAPVP CEEEECCCCCCCCCC | 50.96 | 77070287 | |
360 | Phosphorylation | KVKVEAPSSSPAPVP CEEEECCCCCCCCCC | 50.96 | - | |
361 | Phosphorylation | VKVEAPSSSPAPVPS EEEECCCCCCCCCCC | 39.00 | - | |
362 | Phosphorylation | KVEAPSSSPAPVPSP EEECCCCCCCCCCCC | 29.44 | 26370283 | |
362 | O-linked_Glycosylation | KVEAPSSSPAPVPSP EEECCCCCCCCCCCC | 29.44 | 77070291 | |
368 | Phosphorylation | SSPAPVPSPISQREA CCCCCCCCCCCCCCC | 34.79 | 28066266 | |
371 | O-linked_Glycosylation | APVPSPISQREAPLL CCCCCCCCCCCCCCC | 26.94 | 105050835 | |
371 | Phosphorylation | APVPSPISQREAPLL CCCCCCCCCCCCCCC | 26.94 | 28066266 | |
478 | Phosphorylation | IQIKKSRSRDMQPLF EEEECCCCCCCCCCE | 39.46 | - | |
557 | O-linked_Glycosylation | PPTQEMRSPSPMVAL CCCCCCCCCCCCEEC | 28.55 | 77070297 | |
557 | Phosphorylation | PPTQEMRSPSPMVAL CCCCCCCCCCCCEEC | 28.55 | - | |
579 | Ubiquitination | PLPPADDKLEELIRQ CCCCCHHHHHHHHHH | 59.34 | - | |
665 | Phosphorylation | TKAENPLTPTLSGFL CCCCCCCCCCCCHHH | 18.58 | 25159016 | |
667 | Phosphorylation | AENPLTPTLSGFLES CCCCCCCCCCHHHCC | 28.46 | 25159016 | |
669 | Phosphorylation | NPLTPTLSGFLESPL CCCCCCCCHHHCCHH | 29.94 | 21743459 | |
674 | Phosphorylation | TLSGFLESPLKYLDT CCCHHHCCHHHHCCC | 37.37 | 25159016 | |
674 | O-linked_Glycosylation | TLSGFLESPLKYLDT CCCHHHCCHHHHCCC | 37.37 | 72258545 | |
681 | Phosphorylation | SPLKYLDTPTKSLLD CHHHHCCCCCHHHCC | 30.20 | 30482847 | |
689 | Phosphorylation | PTKSLLDTPAKKAQS CCHHHCCCHHHHHHC | 25.72 | 29109428 | |
772 | Phosphorylation | KWVIRRHTLEEKLLC HHHHHHCCHHHHHHH | 33.77 | - | |
918 | O-linked_Glycosylation | QAYQNQVTNEDVAID HHHHHCCCCCCHHHH | 24.11 | 105050829 | |
1008 | O-linked_Glycosylation | ENQNAKVSSGAIQVL HHHCCCCCCHHHHHH | 23.50 | 77070301 | |
1071 | O-linked_Glycosylation | ALELAGVTTDPGLSL HHHHCCCCCCCCCCC | 25.27 | 77070303 | |
1072 | O-linked_Glycosylation | LELAGVTTDPGLSLK HHHCCCCCCCCCCCC | 37.48 | 77070299 | |
1077 | O-linked_Glycosylation | VTTDPGLSLKGGLSQ CCCCCCCCCCCCCCC | 33.67 | 77070311 | |
1083 | O-linked_Glycosylation | LSLKGGLSQQSLKPS CCCCCCCCCCCCCCC | 29.46 | 55414245 | |
1090 | Phosphorylation | SQQSLKPSLKVEPQN CCCCCCCCCCCCCCC | 38.95 | 21454597 | |
1105 | O-linked_Glycosylation | HFSSFKYSGNAVVES CCCCCEECCCEEEEE | 26.59 | 77070309 | |
1136 | Methylation | SVYSYHSRYAQPGLA HHEEEHHHCCCCCCE | 19.93 | 24129315 | |
1136 | Asymmetric dimethylarginine | SVYSYHSRYAQPGLA HHEEEHHHCCCCCCE | 19.93 | - | |
1252 | O-linked_Glycosylation | VPQLHPASRDPSPFA CCCCCCCCCCCCCCC | 41.49 | 55414237 | |
1252 | Phosphorylation | VPQLHPASRDPSPFA CCCCCCCCCCCCCCC | 41.49 | 26643407 | |
1256 | Phosphorylation | HPASRDPSPFAQSSS CCCCCCCCCCCCCCC | 36.62 | 26643407 | |
1256 | O-linked_Glycosylation | HPASRDPSPFAQSSS CCCCCCCCCCCCCCC | 36.62 | 46304085 | |
1263 | Phosphorylation | SPFAQSSSCYNRSIK CCCCCCCCCCCCCCC | 26.35 | - | |
1263 | O-linked_Glycosylation | SPFAQSSSCYNRSIK CCCCCCCCCCCCCCC | 26.35 | 51512199 | |
1265 | Phosphorylation | FAQSSSCYNRSIKQE CCCCCCCCCCCCCCC | 18.63 | - | |
1271 | Methylation | CYNRSIKQEPIDPLT CCCCCCCCCCCCHHH | 61.09 | 24129315 | |
1282 | O-linked_Glycosylation | DPLTQAESIPRDSAK CHHHCCHHCCCCCCC | 40.69 | 77070317 | |
1293 | O-linked_Glycosylation | DSAKMSRTPLPEASQ CCCCCCCCCCCHHHH | 23.13 | 46304097 | |
1318 | Phosphorylation | YSGGPSMSPKRTNSV CCCCCCCCCCCCCCC | 31.44 | - | |
1351 | Phosphorylation | KLNSFGASCLTPSHF CCCCCCCCCCCCCCC | 15.27 | - | |
1387 | Phosphorylation | RLRGKPWSPCKFGNG CCCCCCCCCCCCCCC | 29.02 | 25159016 | |
1404 | O-linked_Glycosylation | ALTGPSLTEKPWGMG CCCCCCCCCCCCCCC | 46.42 | 77070315 | |
1412 | O-linked_Glycosylation | EKPWGMGTGDFNPAL CCCCCCCCCCCCHHH | 25.37 | 77070305 | |
1442 | Phosphorylation | VEEGRIPTPGANPLD CCCCCCCCCCCCHHH | 31.80 | 26643407 | |
1485 | Phosphorylation | PFSLEEGTAEEPPSK CCCCCCCCCCCCCCC | 33.89 | 28285833 | |
1491 | Phosphorylation | GTAEEPPSKGVVKEE CCCCCCCCCCCCCCC | 53.40 | 28285833 | |
1648 | Phosphorylation | ALAMPTDSAVTVSSY HHCCCCCCCEEEEEE | 27.41 | 28059163 | |
1651 | O-linked_Glycosylation | MPTDSAVTVSSYAYT CCCCCCEEEEEEEEE | 17.87 | 77070329 | |
1653 | O-linked_Glycosylation | TDSAVTVSSYAYTKV CCCCEEEEEEEEEEE | 14.31 | 77070323 | |
1654 | O-linked_Glycosylation | DSAVTVSSYAYTKVT CCCEEEEEEEEEEEC | 14.94 | 77070327 | |
1655 | Phosphorylation | SAVTVSSYAYTKVTG CCEEEEEEEEEEECC | 8.98 | 28059163 | |
1658 | O-linked_Glycosylation | TVSSYAYTKVTGPYS EEEEEEEEEECCCCC | 15.74 | 77070331 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TET3_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TET3_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TET3_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of TET3_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...